|
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 15.13 USD | -0.13% |
|
-.--% | +12.83% |
| May. 21 | Merrimack Pharmaceuticals, Inc.(NasdaqGM:MACK) dropped from S&P Global BMI Index | CI |
| May. 21 | Merrimack Pharmaceuticals, Inc.(NasdaqGM:MACK) dropped from S&P TMI Index | CI |
Merrimack Pharmaceuticals, Inc. reported earnings results for the first quarter ended March 31, 2024. For the first quarter, the company reported net income was USD 201.37 million compared to net loss of USD 0.271 million a year ago. Basic loss per share from continuing operations was USD 0.03 compared to USD 0.02 a year ago.
Basic earnings per share was USD 13.93 compared to basic loss per share of USD 0.02 a year ago.
| 1st Jan change | Capi. | |
|---|---|---|
| +12.83% | 224M | |
| +43.36% | 54.64B | |
| -5.31% | 39.92B | |
| +37.52% | 38.82B | |
| +14.75% | 26.86B | |
| -12.56% | 26.22B | |
| -22.45% | 18.78B | |
| +25.12% | 12.21B | |
| +0.04% | 12.16B | |
| +26.04% | 11.94B |
MERRIMACK PHARMACEUTICALS, INC. 
